These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7626238)

  • 1. Conformational energies of substrates and inhibitors for carboxypeptidase A: stereoelectronic effect.
    Park JK; Cho SJ; Lee S; Kim KS; Kim DH
    J Biomol Struct Dyn; 1995 Apr; 12(5):1033-40. PubMed ID: 7626238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bound ligand motion in crystalline carboxypeptidase A.
    Zhang H; Bryant RG
    Biophys J; 1997 Jan; 72(1):363-72. PubMed ID: 8994621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insight into the stereochemistry in the inhibition of carboxypeptidase A with N-(hydroxyaminocarbonyl)phenylalanine: binding modes of an enantiomeric pair of the inhibitor to carboxypeptidase A.
    Cho JH; Kim DH; Chung SJ; Ha NC; Oh BH; Yong Choi K
    Bioorg Med Chem; 2002 Jun; 10(6):2015-22. PubMed ID: 11937361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of enzyme-bound ligand dynamics by solid-state NMR in the presence of ligand exchange: L-phenylalanine on carboxypeptidase A.
    Zhang H; Bryant RG
    Biophys J; 1995 Jan; 68(1):303-11. PubMed ID: 7711255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hippuryl-alpha-methylphenylalanine and hippuryl-alpha-methylphenyllactic acid as substrates for carboxypeptidase A. Syntheses, kinetic evaluation and mechanistic implication.
    Lee M; Kim DH
    Bioorg Med Chem; 2000 Apr; 8(4):815-23. PubMed ID: 10819170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of ligands to the active site of carboxypeptidase A.
    Rees DC; Lipscomb WN
    Proc Natl Acad Sci U S A; 1981 Sep; 78(9):5455-9. PubMed ID: 6946483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carboxypeptidase A-catalyzed dipeptide synthesis in organic media.
    Vértesi A; Simon LM
    J Biotechnol; 1998 Nov; 66(1):75-82. PubMed ID: 9866861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of circular dichroism to study the interaction of carboxypeptidase A with substrates and inhibitors.
    Arfaoui-Aboulhab L; Jouy M; Fermandjian S; Belhadj O
    Arch Inst Pasteur Tunis; 1986; 63(2-3):289-98. PubMed ID: 3778038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure and dynamics of the metal site of cadmium-substituted carboxypeptidase A in solution and crystalline states and under steady-state peptide hydrolysis.
    Bauer R; Danielsen E; Hemmingsen L; Sorensen MV; Ulstrup J; Friis EP; Auld DS; Bjerrum MJ
    Biochemistry; 1997 Sep; 36(38):11514-24. PubMed ID: 9298972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An angiotensin converting enzyme inhibitor is a tight-binding slow substrate of carboxypeptidase A.
    Martin MT; Holmquist B; Riordan JF
    J Inorg Biochem; 1989 May; 36(1):39-50. PubMed ID: 2746220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The unusual behavior of the inhibitor S(+)(1-amino-2-phenylethyl)phosphonic acid towards carboxypeptidase A.
    Bal W; Bertini I; Kozlowski H; Monnanni R; Scozzafava A; Siatecki GZ
    J Inorg Biochem; 1990 Nov; 40(3):227-35. PubMed ID: 2292683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Principles of hydroxamate inhibition of metalloproteases: carboxypeptidase A.
    Mock WL; Cheng H
    Biochemistry; 2000 Nov; 39(45):13945-52. PubMed ID: 11076537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular dynamics characterization of the active cavity of carboxypeptidase A and some of its inhibitor adducts.
    Banci L; Schröder S; Kollman PA
    Proteins; 1992 Aug; 13(4):288-305. PubMed ID: 1518800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A thioamide substrate of carboxypeptidase A.
    Bartlett PA; Spear KL; Jacobsen NE
    Biochemistry; 1982 Mar; 21(7):1608-11. PubMed ID: 7082637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct chemical evidence for the mixed anhydride intermediate of carboxypeptidase A in ester and peptide hydrolysis.
    Sander ME; Witzel H
    Biochem Biophys Res Commun; 1985 Oct; 132(2):681-7. PubMed ID: 4062944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of potent and specific inhibitors of carboxypeptidases A and B.
    Ondetti MA; Condon ME; Reid J; Sabo EF; Cheung HS; Cushman DW
    Biochemistry; 1979 Apr; 18(8):1427-30. PubMed ID: 427123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the coordination of inhibitors to the metal ion of carboxypeptidase A. A 113Cd and 31P NMR study.
    Gettins P
    J Biol Chem; 1986 Nov; 261(33):15513-8. PubMed ID: 3782076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antinociceptive effect of some carboxypeptidase A inhibitors in comparison with D-phenylalanine.
    Giusti P; Carrara M; Cima L; Borin G
    Eur J Pharmacol; 1985 Oct; 116(3):287-92. PubMed ID: 4076340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative modeling of substrate binding in the S1' subsite of serine carboxypeptidases from yeast, wheat, and human.
    Elsliger MA; Pshezhetsky AV; Vinogradova MV; Svedas VK; Potier M
    Biochemistry; 1996 Nov; 35(47):14899-909. PubMed ID: 8942654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure of carboxypeptidase A complexed with D-cysteine at 1.75 A - inhibitor-induced conformational changes.
    van Aalten DM; Chong CR; Joshua-Tor L
    Biochemistry; 2000 Aug; 39(33):10082-9. PubMed ID: 10955996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.